The 340B Drug Pricing Program is a federal program that allows health centers, like Indiana Health Centers, purchase certain prescription medications at a lower cost.
Because IHC can buy medications at a discount, we are able to:
- Lower medication costs for eligible patients
- Expand services to include things like in-house pharmacy, behavioral health, chiropractic, and care coordination
- Improve facilities
- Purchase new equipment
There is currently a bill proposed that would significantly reduce the amount of 340b funds that would be given to healthcare facilities. As a Federally Qualified Health Center and non-profit, we are asking FSSA/OMPP for an exemption from this proposal.
IHC is asking all patients, staff, and community members to reach out to the Office of the Secretary of Family and Social Services and the Governor’s office to voice your support on including an exception to the proposed update to the 340B Drug Program for FQHC’s.
All comments should be submitted before 5 pm on March 27, 2026.
340B Advocacy Templates
Send to: spacomment@fssa.in.gov, aarbogast@gov.in.gov
Please use the subject line “COMMENT RE: 340B DRUG PROGRAM”
Patient Template
I am a patient at Indiana Health Centers (IHC). I depend on IHC for my care and my medications. Without them, I would not be able to afford the treatment I need to stay healthy.
The 340B program helps IHC provide medications and services that patients like me rely on. With Indiana’s 64% FMAP, for every $10 the state “saves” by taking 340B savings, roughly $6–$7 is effectively given back to the federal government, leaving only about $3–$4 to the state while the full $10 is removed from the medically underserved communities where it’s currently used to expand access and stabilize care.
When the critical access hospital closed in Lawrence County (Bedford), IHC stepped in and used 340B dollars to renovate space so primary care could continue in our community. In Grant County (Marion), IHC used 340B revenue to build a new facility for integrated primary care so patients could receive medical, behavioral health, and pharmacy services in one place.
These savings are currently reinvested directly into communities like mine — not into profits, but into patient care. If this proposal moves forward, it could make it harder for health centers to continue expanding care where it is needed most. Please protect access to care for Medicaid patients. We urge FSSA/OMPP to exempt FQHCs from this proposal.
Community Member Template
As a member of a community served by Indiana Health Centers (IHC), I write to express strong concern regarding the proposed change affecting the 340B Drug Pricing Program and its impact on Federally Qualified Health Centers.
340B savings are not retained as profit — they are reinvested directly into patient care and community stability. When the critical access hospital closed in Lawrence County (Bedford), IHC stepped forward and used 340B revenue to renovate space and ensure continued access to primary care for that community. In Grant County (Marion), 340B savings supported construction of a new integrated primary care facility, expanding access to medical, behavioral health, and pharmacy services under one roof.
These investments are examples of how 340B strengthens Indiana’s healthcare safety net, particularly in rural and underserved areas where access is fragile. Eliminating or restricting these resources for Medicaid patients would destabilize essential access points and reduce services in the communities that can least afford it.
On behalf of IHC and the communities they serve, we urge FSSA/OMPP to exempt FQHCs from this proposal.